Janssen ADC License Agreement with LegoChem Biosciences, Inc.Sexton Riley LLP represented Janssen Biotech, Inc. in a license agreement with LegoChem Biosciences, Inc. for LCB84, a clinical stage Trop2-directed ADC.https://jnjinnovation.com/news/press-releases/legochem-biosciences-announces-license-agreement-for-lcb84-trop2targeted-adc
Sexton Riley LLP represented Janssen Biotech, Inc. in a license agreement with LegoChem Biosciences, Inc. for LCB84, a clinical stage Trop2-directed ADC.https://jnjinnovation.com/news/press-releases/legochem-biosciences-announces-license-agreement-for-lcb84-trop2targeted-adc
Comments